A B S T R A C T The administration of glucocorticoids may decrease intestinal calcium absorption in vivo and the active transport of calcium in rat duodenum in vitro. It has been suggested that this apparent "anti-vitamin D-like" effect of steroid hormones may be related to alterations in vitamin D metabolism. In order to test this hypothesis, vitamin D-deficient control and cortisone-treated rats were given an intraperitoneal injection of 5.5 IU of 1,25-dihydroxycholecalciferol (1,25-DHCC), the probable end-organ active vitamin D metabolite in the intestine, and 16 h later studies of duodenal calcium transport were performed in modified Ussing chambers. In the vitamin D-deficient state, cortisone administration was associated with a diminution in Jms, JNet, and the flux ratio (Jms/JsM). While the magnitude of the increases in Jms and JNet that resulted fromi 1,25-DHCC treatment were approximately the same in control and cortisone-treated animals, 1,25-DHCC failed to restore these parameters to "normal levels" in the steroid-treated rats. Furthermore, contrary to the results obtained in the saline-treated controls, 1,25-DHCC failed to reduce Jsm in the duodenum from cortisone-treated rats. The cortisone-related defect in calcium transport was due to alterations in both unidirectional calcium fluxes (decrease in Jms and increase in Jsm), such that the JNet and the flux ratio (Jms/Jsm) were only approximately 50% of the levels achieved in vitamin D-deficient control animals repleted with the same dose of 1,25-DHCC.
INTRODUCTION
The administration of glucocorticoids may decrease the intestinal absorption of dietary calcium in normal humans (1) , as well as in those with sarcoidosis and vitamin D intoxication (2, 3) . Furthermore, these hormones can decrease the active transport of calcium in vitro with preparations of rat small intestine (4) (5) (6) .
It has been shown that cortisone administration in the rat does not affect the hepatic conversion of cholecalciferol, the parent vitamin D3, to its circulating active form, ' (6, 7) . Moreover, the impairment in calcium transport in the intestine of cortisone-treated animals cannot be corrected by the administration of pharmacologic doses of either cholecalciferol or 25-HCC (6) . These observations have led to the concept that the apparent antagonism between vitamin D and glucocorticoid administration may be due to either: (a) a steroid hormone-related defect in the formation and/or localization of the more polar dihydroxyl tissue active forms of the vitamin; or (b) an influence of glucocorticoids on the cellular mechanisms mediating calcium transport in a manner that is independent of any direct interaction with the parent vitamin or its metabolites (6) (7) (8) .
There is now a great deal of evidence to indicate that 25-HCC, formed from the parent vitamin in the liver (9) , is subsequently converted in the kidney (10) (11) (12) to a more polar metabolite that has been shown to be 1,25-dihydroxycholecalciferol (1,25-DHCC) (13) (14) (15) . This latter dihydroxyl metabolite is the predominant form of the vitamin in the intestinal mucosa (16, 17) , and it is probably the end-organ active form of the vitamin in the gut (18, 19) . Recent animal studies in this laboratory demonstrated that cortisone administration influences neither the metabolic conversion of 25-HCC to 1,25-DHCC nor the localization of this metabolite in end organs including intestinal mucosa (8) . The results of these studies strongly suggested that defective calcium transport following cortisone administration in the rat is not due to an alteration in the production or localization of 1,25-DHCC.
The present study was undertaken to determine directly whether or not the administration of Transport studies. 16 h following the administration of either 1,25-DHCC or the vehicle, the fasting animals were stunned by concussion and exsanguinated. Blood was collected for subsequent determinations of serum calcium and magnesium by atomic absorption spectrometry and of serum inorganic phosphorous by the method of Fiske and Subbarow (20) . Unidirectional transmural fluxes of calcium across the proximal duodenum were studied in vitro using a modification of the apparatus of Ussing and Zerahn (21) as described by Walling and Rothman (22) (23) , and only mean steady-state values are reported.
Electrical measurements on the mounted tissues were made in a manner similar to that described by Field, Fromm, and McColl (24) . The transmural electric potential difference (PD) across the mounted duodenum was monitored at the beginning and end of the experiment and was otherwise nulled by passing a short-circuit current (SCC).
Tissue resistance was measured at 60 min, after the preparation was permitted to reach steady state under opencircuited conditions.
Statistical analyses. Paired t tests were employed to determine the significance of differences between JMs and Jsm within groups. Since JNet is a dependent variable of JmS and JsM, two-tailed t tests were used to evaluate differences in JNet between the various treatment groups. Oneway analyses of variance were employed to examine differences between JMS, JSSI and serum chemistries in the various groups, and a table of "least significant difference" was constructed to evaluate confidence intervals (25) . RESULTS The effects of 1,25-DHCC administration on in vitro duodenal calcium transport and on serum levels of calcium, magnesium, and phosphorous in control and cortisone-treated, vitamin D-deficient rats are summarized in Tables I and II . Net fluxes, JNet in the absorptive direction and ratios of Jms/Jsm in excess of 1.0, findings consistent with active calcium transport in the duodenum, were observed in all but the vitamin D-deficient, cortisone-treated group where Jsm actually exceeded a markedly reduced Jms, resulting in net calcium secretion (Table I) . While the magnitude of the increases in Jms and in JNet which resulted from 1,25-DHCC treatment were approximately the same in both control and cortisone-treated animals, 1,25-DHCC failed to restore these parameters to "normal levels" in the steroid-treated group. Furthermore, contrary to the results obtained in the saline-treated controls, 1,25-DHCC did not reduce Jsm in the duodenum from cortisone-treated animals. The failure of 1,25-DHCC to completely overcome the cortisone-related defect in JMS, Another noteworthy effect of cortisone administration was found in the measurements of PD and SCC in the group given both cortisone and 1,25-DHCC (Table I) .
These values were nearly double those observed in the other three groups, while the resistance of the intestine was the same for all groups. These changes in PD and SCC are probably related to the enhanced transport of glucose (26) observed in the small intestine of glucocorticoid-treated rats, if the stimulation in SCC is assumed to be the result of sodium and glucose cotransport (23) . Of note is the fact that the effect of cortisone administration on the transmural PD was not observed in a previous study from this laboratory (6) in which fructose, a nonactively transported hexose, replaced glucose in the incubation medium.
As noted in Table II , serum calcium levels were initially somewhat higher in the cortisone-treated, vitamin D-deficient animals than in the vitamin D-deficient controls. While the administration of 1,25-DHCC was P <0.001. 9 1,25-DHCC, cortisone Jms > 1,25-DHCC, cortisone JsM; P < 0.005. 10Vitamin D-deficient, saline JNet > Vitamin D-deficient, cortisone JNet; P < 0.005. 11 1,25-DHCC, saline JNet > vitamin D-deficient, saline JNet; P < 0.005. 12 1,25-DHCC, saline JNet > 1,25-DHCC, cortisone JNet; P < 0.01. 13 1,25-DHCC, cortisone JNet > vitamin D-deficient, cortisone JNet; P < 0.001. 14 1,25-DHCC, cortisone PD60 > 1,25-DHCC, saline PD6o; P <0.001. 15 1,25-DHCC, cortisone PD60 > vitamin D-deficient, cortisone PD60; P < 0.001. 16 1,25-DHCC, cortisone IsCC60 > 1,25-DHCC, saline Iscc60; P <0.001. 17 1,25-DHCC, cortisone Iscc60 > vitamin D-deficient, cortisone IsCc60; P < 0.001. 18 Tissue resistances for all groups are not different; F3, 23 = 1.147; P < 0. 25. followed by a striking increase in the serum calcium levels of control rats, there was no such response in the cortisone-treated group. 1,25-DHCC caused a moderate elevation in serum phosphate levels in both the control and cortisone-treated groups, whereas serum magnesium levels were uninfluenced by all of the experimental conditions. DISCUSSION The results of the present study show that a 5.5 IU dose of 1,25-DHCC failed to restore duodenal calcium transport to "normal levels" in vitamin D-deficient, cortisone-treated rats. The cortisone-related defect in calcium transport is due to alterations in both uni- (27) provided evidence suggesting that the administration of prednisone to normal human volunteers might interfere with the conversion of vitamin D3 (cholecalciferol) to 25-HCC. Unfortunately, only the plasma metabolites were studied, and these were examined at only one point in time (24 h ), during what may represent the early phase of a biphasic semilogarithmic disappearance curve with the half-life of the second phase measurable in weeks (28) . Recently, Kimberg, Baerg, Gershon, and Graudusius (6) and Schaefer, von Herrath, Koch, and Opitz (7) reported that cortisone treatment in the rat does not interfere with the conversion of vitamin D3 to 25-HCC. It was furthermore shown that the administration of multiple pharmacologic doses of cholecalciferol (12,000 IU) or 25-HCC (50 IU) to glucocorticoidtreated animals failed to completely correct the hormone-related defect in intestinal calcium transport (6) . Based on the results of these previous studies (6, 7) it was clear that if indeed cortisone exerted its apparent anti-vitamin D-like effect by interfering with the metabolism of vitamin D, it did so at a step subsequent to 25-hydroxylation in the liver.
At the present time there is good reason to believe that 1,25-DHCC is the end-organ active metabolite of vitamin D in the intestine (13) (14) (15) (16) (17) (18) (19) . Recent studies in this laboratory (8) (6, 29) or with the vitamin D-related rise in inEffects of 1,25-Dihydroxycholecalciferol After Cortisone Administration testinal mucosal Ca++-ATPase activity (29). Moreover, it has been shown that glucocorticoid administration impairs intestinal iron transport (6) and enhances the transport of both glucose (26) and galactose (6) . Although these transport functions are presumably not directly dependent upon vitamin D (30), calcium and iron (31) , and calcium and actively transported hexoses (30) may compete for one or more constituents or reactions involved in transmural transport. The present observation that the cortisone-induced increases in PD and SCC, presumably due to sodium and glucose cotransport occurred only after 1,25-DHCC administration, suggests that in this regard there may be some type of a synergistic interaction between the steroid hormone and the vitamin.
The significant elevation in serum calcium concentration following 1,25-DHCC administration in control animals and the lack of such a response to the vitamin D metabolite following cortisone treatment, suggests that glucocorticoids may, in addition to their effects on the intestine, alter the bone-mobilizing properties of 1,25-DHCC (32) . Further studies will be required to elucidate the nature of the interaction of 1,25-DHCC and cortisone on both bone metabolism and certain intestinal transport mechanisms. Finally, the relevance, if any, of the present observations to those clinical situations in which glucocorticoids may lower serum calcium levels remains to be established (2, 3) .
